BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 17, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 22, 2021
View Archived Issues
Pyxis Oncology enters worldwide agreement with Pfizer to develop and commercialize novel ADCs
Read More
Dyadic plans to conduct first-in-human study of its SARS-CoV-2-S-RBD vaccine candidate, DYAI-100
Read More
The omnivore's dilemma
Read More
Dopamine plays role in pain perception sex differences
Read More
Reprogrammed cells repair vasculature, brains after stroke
Read More
FDA approves Ponvory as oral treatment for adults with relapsing multiple sclerosis
Read More
Updated phase Ib data presented for PF-06939926 in boys with DMD
Read More
Novel C3 conditional knockout mouse model of AD
Read More
Response to tabelecleucel leads to long-term survival in patients with EBV+ PTLD following HCT
Read More
UNM Rainforest Innovations patents ER modulators
Read More
Korea Institute of Science and Technology divulges protein kinase inhibitors
Read More
Etern Biopharma presents new FGFR inhibitors
Read More
Janssen Pharmaceutica synthesizes new DHODH inhibitors
Read More
Bio-Thera Solutions presents new anti-TIGIT antibodies
Read More
Enrollment opens in first-in-human study of mRNA-3927 for propionic acidemia
Read More
IMpower010 study of Tecentriq in NSCLC meets DFS primary endpoint
Read More
enGene enrolls patients with non-muscle invasive bladder cancer in phase I/II study of EG-70
Read More
ARTham Therapeutics provides first phase I data for ART-001 in healthy volunteers
Read More
Cellphire initiates phase II study of Thrombosomes for bleeding in patients with thrombocytopenia
Read More
Studies identify novel PDAC therapeutic target
Read More
AZP-3601 shows promising preliminary data in healthy male subjects
Read More
U.S. phase III trial of AZD-1222 for COVID-19 meets primary efficacy endpoint at interim analysis
Read More
China NMPA clears start of phase III trial of Endostar for malignant thoracoabdominal effusions
Read More
BioAge begins phase II trial of BGE-175 in older patients with COVID-19
Read More
